|
|
|
|
Primary obstacles for clinical trials include difficulty identifying suitable candidates, insufficient awareness of trial opportunities, and limited direct engagement between sponsors and potential participants. Quest seeks to ensure that clinical trials secure the necessary participant numbers, ultimately enhancing the viability of clinical research.
|
|
|
|
|
Real-world data (RWD) is transforming clinical trial efficiency by optimizing patient screening and selection. Explore six key ways laboratory data strengthens the clinical trial process, focusing on how RWD enhances patient recruitment, accelerates screening workflows, and improves overall study outcomes.
|
|
|
|
|
Colorectal cancer is the third most common cancer worldwide and the second leading cause of cancer-related deaths. Real-world data is transforming CRC research by complementing traditional clinical trials, accelerating drug development, and improving patient outcomes.
|
|
|
|
|
Multiple myeloma (MM) remains a challenge in the field of hematologic malignancies due to its genetic complexity and varied clinical manifestations. Explore how therapeutic area datasets assist in addressing these challenges and accelerate transformative MM treatment developments.
|
|
|
|
|
Decentralized Clinical Trials (DCTs) are revolutionizing drug development by enhancing patient access, improving data quality, and streamlining study operations. To fully realize these benefits, an advanced clinical trial testing infrastructure is essential.
|
|
|
|
|
Using clinical data to identify patients promptly is critical to improving trial outcomes. When recruiting eligible patients for a trial centered around a rare, life-threatening blood disorder, a leading pharmaceutical company collaborated with Quest Diagnostics to overcome the data latency challenges associated with traditional EHR.
|
|
|
|
|
|
Accelerating Trial Enrollment With Data-Driven Outreach
|
Patient enrollment remains one of the most critical challenges in clinical trial execution, with difficulties in identifying eligible participants often leading to delays and increased costs. Quest Diagnostics challenges by leveraging its extensive clinical database of over 300 million patients to streamline patient identification and enhance enrollment strategies.
|
|
• Request Information
|
|
|
|
|
|
|
|
|
|
|
Data Licensing For Clinical Trial Planning
|
Quest Diagnostics' data licensing solutions enhance clinical trial planning by optimizing site selection, investigator identification, and regulatory compliance. With a vast deidentified database, Quest provides data-driven insights to improve enrollment, reduce costs, and meet FDA Diversity Action Plan (DAP) requirements.
|
|
• Request Information
|
|
|
|
|
|
|
|
|
|
|
|
